Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This trial employs a randomized, double-blind, placebo/positive control, and dose-finding design to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of SIBP-A16 injection in premature and term infants.
Epistemonikos ID: 7db530b9971000f22b88b2e2b77ba4468a3a3c28
First added on: Jan 24, 2026